Abstract Developing therapeutics against SARS-CoV-2 could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein, but also across the full Spike (S) protein. We isolated and characterized monoclonal […]

Click here to view original web page at A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2